Form 4 for INCY Incyte
Accepted 2026-04-21 16:09:07 ET · period of report 2026-04-17 · accession 0001205703-26-000012 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2026-04-21 16:09 | 2026-04-17 | INCY | CAGNONI PABLO J | Pres, Gbl Head of R, D | M - OptEx | $69.43 | +18.7K | 281.4K | +7% | +$1.30M |
| DT | 2026-04-21 16:09 | 2026-04-17 | INCY | CAGNONI PABLO J | Pres, Gbl Head of R, D | S - Sale+OE | $96.50 | -18.7K | 262.7K | -7% | -$1.80M |
| DMT | 2026-04-21 16:09 | 2026-04-17 | INCY | CAGNONI PABLO J | Pres, Gbl Head of R, D | M - OptEx | $0.00 | -18.7K | 27.7K | -40% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-04-17 | M | A | 6,077 | $64.25 | 268,769 | D | — | — | |
| 2 | Common | Common Stock | 2026-04-17 | M | A | 12,590 | $71.93 | 281,359 | D | — | — | |
| 3 | Common | Common Stock | 2026-04-17 | S | D | 18,667 | $96.50 | 262,692 | D | — | — | (F1) This includes an aggregate of 257,553 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested. |
| 4 | Derivative | Employee Stock Option (right to buy) | 2026-04-17 | M | D | 6,077 | $0.00 | 26,833 | D | $64.25 · — to 2034-07-14 | 6,077 Common Stock | (F2) The July 15, 2024 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years. |
| 5 | Derivative | Employee Stock Option (right to buy) | 2026-04-17 | M | D | 12,590 | $0.00 | 27,699 | D | $71.93 · — to 2035-01-16 | 12,590 Common Stock | (F3) Beginning January 17, 2025, options become exercisable in 37 installments, with the first 25% vesting on July 15, 2025 and the remainder vesting monthly over three years. |